Literature DB >> 22288899

Advanced treatment modalities for vitiligo.

Nishit S Patel1, Kapila V Paghdal, George F Cohen.   

Abstract

BACKGROUND: Vitiligo is an acquired multifocal and polygenic dyschromia that affects 1% to 3% of the world and presents as multiple depigmented macules and patches. Traditionally, the treatment of vitiligo has focused on pharmacologic interventions, but nearly half of all treated patients fail to respond successfully.
OBJECTIVE: Several advanced techniques exist that can aid dermatologists in treating vitiligo in patients who do not respond favorably to traditional pharmacologic treatments. These advanced interventions include the use of the 308-nm excimer laser, total body depigmentation therapy with monobenzyl ether of hydroquinone, microdermabrasion, micropigmentation, khellin-UVA therapy, and surgical management using miniature punch grafting, suction blister grafting, and epidermal cultures.
MATERIALS AND METHODS: This article reviews the current literature on these advanced treatment modalities for vitiligo and provides a practical guide for application of these techniques. RESULTS AND
CONCLUSION: Our ability to treat vitiligo may be imperfect, but through appropriate patient selection and careful application of one or more of these advanced therapies, successful treatment of vitiligo, even in patients refractory to treatment, can be achieved.
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22288899     DOI: 10.1111/j.1524-4725.2011.02234.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  8 in total

1.  Differentially Expressed Circular RNAs and Their Therapeutic Mechanism in Non-segmental Vitiligo Patients Treated With Methylprednisolone.

Authors:  Jiaqi Zhang; Ning Liang; Yan Cao; Min Li
Journal:  Front Med (Lausanne)       Date:  2022-05-16

2.  Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome.

Authors:  M El-Domyati; W H El-Din; A F Rezk; I Chervoneva; J B Lee; M Farber; J Uitto; O Igoucheva; Vitali Alexeev
Journal:  Arch Dermatol Res       Date:  2021-04-17       Impact factor: 3.017

Review 3.  Role of Recipient-site Preparation Techniques and Post-operative Wound Dressing in the Surgical Management of Vitiligo.

Authors:  Nour Al-Hadidi; James L Griffith; Mohammed S Al-Jamal; Iltefat Hamzavi
Journal:  J Cutan Aesthet Surg       Date:  2015 Apr-Jun

Review 4.  Vitiligo--Part 2--classification, histopathology and treatment.

Authors:  Adriane Reichert Faria; Roberto Gomes Tarlé; Gerson Dellatorre; Marcelo Távora Mira; Caio Cesar Silva de Castro
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

5.  Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial.

Authors:  Fariba Iraji; Ali Asilian; Zahra Talebzadeh; Mina Saber; Fatemeh Mokhtari; Amirhossein Siadat; Seyed Mohsen Hosseini
Journal:  Dermatol Res Pract       Date:  2021-11-30

6.  The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study.

Authors:  Farahnaz Fatemi Naini; Alireza Vaez Shooshtari; Bahareh Ebrahimi; Razieh Molaei
Journal:  J Res Pharm Pract       Date:  2012-10

7.  Serum Zinc Level in Vitiligo: A Case-control Study.

Authors:  Mina Mirnezami; Hoda Rahimi
Journal:  Indian J Dermatol       Date:  2018 May-Jun       Impact factor: 1.494

8.  Effect of serum from healthy individuals on the growth of melanocytes in vitro following moxibustion at the "Jiudianfeng" point.

Authors:  Rupeng Liu; Tianhui Niu; Yu Cheng; Dongmei Zhou; Cang Zhang; Jianhua Qu; Liyun Sun; Guangjin Guo; Ran Gao; Guang Zhao; Jusheng Wang
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.